ENANTIOS

molecule characterization method, which addresses critical bottlenecks in traditional drug development

Total raised

€1.9M

€1,870,919

Funding rounds

Investors

distinct backers

Active since

2024-06

latest 2024-06

Funding by year

EUR raised per year

High confidence

Raise-next likelihood33

base rate 30% for Other

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2024-06-27	Other	€1.9M	Private Investors,Privilège Ventures,Zürcher Kantonalbank	View deal →

same sector or country